SOLARA ACTIVE PHARMA SCIENCES
Back to All Ratios
|
SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Core EBITDA Growth(%) | -10.11 | 338.95 | -157.41 | 56.45 | -75.89 |
What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?
| Year | Core EBITDA Growth |
|---|---|
| Mar2026 | -10.11 |
| Mar2025 | 338.95 |
| Mar2024 | -157.41 |
| Mar2023 | 56.45 |
| Mar2022 | -75.89 |
How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?
| Years | Core EBITDA Growth | % Change | |
|---|---|---|---|
| Mar2026 | -10.11 | Negative | |
| Mar2025 | 338.95 | Positive | |
| Mar2024 | -157.41 | Negative | |
| Mar2023 | 56.45 | Positive | |
| Mar2022 | -75.89 | - | |
Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOLARA ACTIVE PHARMA SCIENCES | ₹3,621.1 Cr | -1% | 20.6% | 11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOLARA ACTIVE PHARMA SCIENCES | -1% |
20.6% |
11.6% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses